Vaccine Safety Datalink (VSD)

Current (+ Future) Vaccine Safety Data Sources. Robert T. Chen MD, MA Vaccine Safety and Development Activity National Immunization Program

Current (+ Future) Vaccine Safety Data Sources Robert T. Chen MD, MA Vaccine Safety and Development Activity National Immunization Program Outline Current data sources Pre-licensure Post-licensure Strengths

Immunization Safety Office: Overview and Considerations on Safety of Alternative Immunization Schedules

Immunization Safety Office: Overview and Considerations on Safety of Alternative Immunization Schedules Frank DeStefano MD, MPH Immunization Safety Office Division of Healthcare Quality Promotion, National

US Efforts in Vaccine Safety. Roger Baxter, MD California Immunization Coalition Summit 2011

US Efforts in Vaccine Safety Roger Baxter, MD California Immunization Coalition Summit 2011 Conflicts of interest I receive research grants from Sanofi Pasteur, GSK, Merck, MedImmune, Novartis, Pfizer,

Walter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development Associate Director, Emory Vaccine Center

Could Vaccines be a Possible Model For Pediatric Drug Development? June 13, 2006 Walter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development Associate

Deployment of Combination Vaccines and STI vaccines

Deployment of Combination Vaccines and STI vaccines Advancing Prevention Technologies for Sexual and Reproductive Health Symposium Berkeley, Ca March 24, 2009 Eileen Yamada, MD, MPH California Department

Review of Safety of Thimerosal-Containing Vaccines: a Two- Phased Study of Computerized Health Maintenance Organization Databases (Pediatrics 2003)

Review of Safety of Thimerosal-Containing Vaccines: a Two- Phased Study of Computerized Health Maintenance Organization Databases (Pediatrics 2003) Introduction Review of Verstraeten findings focused on

Risk of Seizures following Measles Containing Vaccination in Children Born Preterm or Full-term

Risk of Seizures following Measles Containing Vaccination in Children Born Preterm or Full-term David L. McClure HSCRN 2018 Annual Meeting 1 Acknowledgements Co-authors Huong McLean Steven Jacobsen Nicola

Sentinel Initiative Public Workshop. The Brookings Institution Marriott at Metro Center Washington, DC Tuesday, January 14, 2014

Sentinel Initiative Public Workshop The Brookings Institution Marriott at Metro Center Washington, DC Tuesday, January 14, 2014 State of CBER s Mini-Sentinel Activities Michael Nguyen, MD Division of Epidemiology

Responding to Vaccine Safety Events

Responding to Vaccine Safety Events Karen Midthun, MD, Deputy Director Center for Biologics Evaluation and Research, FDA ICDRA Conference Berne, Switzerland September 19, 2008 1 Vision for CBER INNOVATIVE

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 ) 4. Worldwide Pediatric Vaccines Market Share

Vaccine safety messages

Vaccine safety messages This document is intended to support immunization programme managers and staff in their efforts to secure sustainable funding for immunization. HOW TO USE THIS DOCUMENT Many people

Schools. Kindergarten

1 of 5 7/29/2014 4:14 PM Schools North Carolina law requires all children in the state to receive certain immunizations. Records are checked when children enter school or child care. Kindergarten Vaccination

Autism and Childhood MMR Vaccine Draft of Analysis Plan. September 5, 2001

Autism and Childhood MMR Vaccine Draft of Analysis Plan September 5, 2001 Introduction Autism is a serious life-long developmental disorder characterized by marked impairments in social interactions, and

Autism and Childhood MMR Vaccine Draft of Analysis Plan September 5, 2001 Introduction Autism is a serious life-long developmental disorder characterized by marked impairments in social interactions, and

Population-based post-licensure safety surveillance

Population-based post-licensure safety surveillance Nick Andrews, Public Health England With thanks to Paddy Farrington, Open University for contributing some SCCS slides ADVAC May 27 th 2016 Aims of the

Assessing the Safety of Vaccines at the FDA: Pre- and Post-Licensure Evaluation

Assessing the Safety of Vaccines at the FDA: Pre- and Post-Licensure Evaluation Karen Farizo, M.D. Office of Vaccines Research and Review Center for Biologics Evaluation and Research US Food and Drug Administration

Safety of Vaccines Used for Routine Immunization in the United States Executive Summary

Evidence Report/Technology Assessment Number 215 Safety of s Used for Routine Immunization in the United States Executive Summary Background s are considered one of the greatest public health achievements

Using Epidemiology to Identify the Cause of Disease: Cohort study

Using Epidemiology to Identify the Cause of Disease: Cohort study Sakda Arj-ong Vallipakorn, M.D., MSICT., MSIS., PhD.(Clinical Epidemiology) Pediatrics, Pediatric Cardiology Emergency Medicine, Pediatric

Influenza Vaccine Safety Monitoring Update

Influenza Vaccine Safety Monitoring Update Advisory Committee on Immunization Practices October 28, 2010 Tom Shimabukuro, MD, MPH, MBA Immunization Safety Office Division of Healthcare Quality Promotion,

Assessing Vaccine Safety Post Licensure. Neal A. Halsey Johns Hopkins University

Assessing Vaccine Safety Post Licensure Neal A. Halsey Johns Hopkins University Inactivated Respiratory Syncytial Virus Vaccine: 1960 s Formalin inactivated Administered to infants Minimal reactions Induced

'Contagious Comments' Department of Epidemiology

'Contagious Comments' Department of Epidemiology Vaccine-Preventable Diseases in Colorado s Children, 27 Sean O Leary MD, Elaine Lowery JD MSPH, Carl Armon MSPH, James Todd MD Vaccines have been highly

Immunization Update Texas Immunization Conference

Immunization Update 2017 Texas Immunization Conference Agenda NIS Child and Teen Coverage Levels Adult Program Updates TVFC Influenza Updates TVFC Program Updates 2 1 CDC National Immunization Survey Childhood

US Rotavirus Vaccination Program

US Rotavirus Vaccination Program 1 Rotavirus Vaccines in US Feb 2006 Feb 2006 April 2008 June 2008 RotaTeq licensed by FDA RotaTeq recommended by ACIP Rotarix licensed by FDA ACIP to consider Rotarix 2

Langston University Student Health Services Policies and Forms October 3, 2016

Langston University Student Health Services Policies and Forms October 3, 2016 Official Notice: Immunization Requirements for Langston University Students Oklahoma state law requires that all new students

Perspectives on Improving International Vaccine Safety

Perspectives on Improving International Vaccine Safety Robert Ball, MD, MPH, ScM Director, Office of Biostatistics and Epidemiology Center for Biologics Evaluation and Research U.S. Food and Drug Administration

VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine

VACCINES TRIUMPHS AND TRIBULATIONS William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine Never in the history of human progress has a better and cheaper

Public Health Wales Vaccine Preventable Disease Programme

Public Health Wales Vaccine Preventable Disease Programme LHB practice level reports Cwm Taf LHB July June August Page of Contents. Purpose and Background.... LHB Summary.... Practice level data Merthyr

Connecting the data to the science: A biostatistician s role in advancing safety knowledge

Connecting the data to the science: A biostatistician s role in advancing safety knowledge Jennifer Clark Nelson, PhD Director of Biostatistics Group Health Research Institute Affiliate Professor of Biostatistics

Vaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines

Vaccine Innovation: Challenges and Opportunities to Protect Health Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines Protecting Health with Vaccines HEALTH IMPROVEMENT Population Impact Guidelines

Healthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.

Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy

Student Immunization Record Part I Student Information

Student Immunization Record Part I Student Information Student ID#: Last Name: First Name: _ MI: Date of Birth: Sex: Phone Number: E-mail: Parts II - IV are to be completed by a Healthcare provider. All

WHY WE RE HERE. Melinda Wharton, MD, MPH Director, Immunization Services Division. National Center for Immunization & Respiratory Diseases

National Center for Immunization & Respiratory Diseases WHY WE RE HERE Melinda Wharton, MD, MPH Director, Immunization Services Division AIM Leadership Conference February 8, 2017 Vaccines save lives.

Quest for Quality: Immunizations

Quest for Quality: Immunizations DANE COUNTY IMMUNIZATION COALITION MEMBERSHIP MEETING November 13, 2012 Elaine Rosenblatt MSN, FNP-BC Director, Quality and Care Management UW Medical Foundation/ Unity

Vaccine Update Paul A. Offit, MD Division of Infectious Diseases Vaccine Education Center The Children

Vaccine Update Paul A. Offit, MD Division of Infectious Diseases Vaccine Education Center The Children s Hospital of Philadelphia Perelman School of Medicine The University of Pennsylvania Topics Hep A:

Working Together: Using IIS to Support Immunization Program Goals and Activities

Working Together: Using IIS to Support Immunization Program Goals and Activities Mary Woinarowicz, MA NDIIS Manager/Sentinel Site Coordinator Molly Howell, MPH Immunization Program Manager Background NDDoH

Exercise: Estimating immunization program costs (~60 minutes)

Exercise: Estimating immunization program costs (~60 minutes) Overview Information on the cost of procuring vaccines and of running national immunization program is a key factor in planning and managing

Establishing a second-year-of-life (2YL) healthy child visit

Establishing a second-year-of-life (2YL) healthy child visit Dr Rudi Eggers Presentation to the Global Vaccines and Immunization Research Forum Sandton, 15 March 2016 Session Objectives Provide an overview

Changes for the School Year. The addition of NINTH grade to the requirement for four (4) doses of diphtheria, tetanus, and pertussis.

February 19, 2013 Dear Immunization Provider: In accordance with South Carolina Code of Laws, Section 44-29-180, and State Regulation 61-8, the 2013-2014 "Required Standards of Immunization for School

What You Need to Know about Vaccine Safety

What You Need to Know about Vaccine Safety Melinda Wharton, MD, MPH Director, Immunization Services Division National Center for Immunization & Respiratory Diseases Increasing HPV Vaccination in the United

Targeted Diseases and Immunization. Strategic plan

Targeted Diseases and Immunization Strategic plan 2008-2013 Communicable Diseases Unit WHO Regional Office for Europe Mission To provide technical support to WHO European Region Member States to ensure

Estimating U.S. national vaccination coverage using IIS Sentinel Site data

National Center for Immunization & Respiratory Diseases Estimating U.S. national vaccination coverage using IIS Sentinel Site data Xia Lin, PhD, MSPH Immunization Services Division IIS Support Branch AIRA

Workshop Overview. The Problem. National Milestones. The Registry Solution. Benefits of Registry/Managed Care Collaboration

Using Immunization Registry Data to Support Medicaid Managed Care Services Noam H. Arzt, PhD HLN Consulting, LLC arzt@hln.com The New York City Experience Martha Rome, BSN, MPH Medical and Health Research

Methodologies for vaccine safety surveillance. Nick Andrews, Statistics Unit Public Health England October 2015

Methodologies for vaccine safety surveillance Nick Andrews, Statistics Unit Public Health England October 2015 Some dramas of the past 20 years which do you think turned out to be real adverse reactions?

Vaccine Finance. Overview of stakeholder input and NVAC working group draft white paper. Walt Orenstein, MD

Vaccine Finance Overview of stakeholder input and NVAC working group draft white paper Walt Orenstein, MD Consultant to the National Vaccine Program Office July 24, 2008 Number of Vaccines in the Routine

Lessons Learned from Adverse Events and Assessment of Causal Relationships. Neal A. Halsey Johns Hopkins University

Lessons Learned from Adverse Events and Assessment of Causal Relationships Neal A. Halsey Johns Hopkins University Lessons Learned 1000s of lessons learned Many vaccines not successful Some caused harm

COMBINATION VACCINES: HOW AND WHY? LESSONS LEARNED.

COMBINATION VACCINES: HOW AND WHY? LESSONS LEARNED. Global Vaccine and Immunization Research Forum Johannesburg, March 16, 2016 Michel De Wilde, MDWConsultant, LLC STRONG RATIONALE EXISTS FOR COMBINATION

Towards the Achievement of GHSA 2024 s Overarching Targets

정보화파트업무계획 [GHSA] Immunization Towards the Achievement of GHSA 2024 s Overarching Targets 2016년추진업무및 2017년업무계획 ( 사업관리 ) 7 th November 2018 Korea Centers for Disease Control and Prevention I. Overview Contents

Objectives. Immunity. Diphtheria. Immunization Update July 22, Individual Immunity

Immunization Update July 22, 2008 Presented by Robert Brayden, MD Associate Professor, UCHSC Child Health Clinic, The Children s s Hospital Hosted by: Community Health Association of Mountain/Plains States

The Pentavalent Rotavirus Vaccine, RotaTeq : From Development to Licensure and Beyond

The Pentavalent Rotavirus Vaccine, RotaTeq : From Development to Licensure and Beyond Max Ciarlet, PhD Vaccines Clinical Research Department Merck Research Laboratories North Wales, Pennsylvania, United

Rural Minority Children's Access to and Timeliness of Immunizations:

Rural Minority Children's Access to and Timeliness of Immunizations: 1993-2001 South Carolina Rural Health Research Center Arnold School of Public Health Department of Health Services Policy & Management

Findings from a Mini-Sentinel Medical Product Assessment: Influenza Vaccines and Risk of Febrile Seizures

Brookings Webinar on Active Medical Product Surveillance Findings from a Mini-Sentinel Medical Product Assessment: Influenza Vaccines and Risk of Febrile Seizures Engelberg Center for Health Care Reform

I protected my future

I protected my future I had all my vaccinations Ask at home today if you ve had your vaccinations. Developed by Pfizer Ltd in collaboration with PHE and Wiltshire Council. March 2014. NPSC0069c Everybody

Recommended Health Screenings

Recommended Health Screenings UnitedHealthcare appreciates the preventive care you deliver to our members. Please use the below health screening chart to schedule screenings based on the member s age and

What s New In Pediatric Vaccines? and Addressing Vaccine Hesitancy

What s New In Pediatric Vaccines? and Addressing Vaccine Hesitancy Kathryn M. Edwards MD Sarah H. Sell and Cornelius Vanderbilt Chair Professor of Pediatrics Vanderbilt University Medical Center Disclosures

Varicella (Chickenpox) and Varicella Vaccines

Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Varicella (Chickenpox) and Varicella Vaccines September 2018 Photographs and images included in this

Vaccination Decision Making: What Providers Need to Know

Objectives Vaccination Decision Making: What Providers Need to Know Kelli Smith, RN, BSN Iowa Department of Public Health Immunization Program Catch-up Schedule: how to most efficiently bring persons up-to-date

Results of the 2013 Immunization Status Survey of 24-Month-Old Children in Tennessee

Results of the 2013 Immunization Status Survey of 24-Month-Old Children in Tennessee Prepared by the Tennessee Immunization Program Tennessee Department of Health http://health.state.tn.us/ceds/immunization.htm

California Department of Public Health California Department of Public Health California Department of Public Health

2012 CIC Education Hour: January 24, 2012 Navigating Adolescent Vaccinations through Private and Safety Net Providers Contact Information Claudia Aguiluz, VFC Program Coordinator Claudia.aguiluz@cdph.ca.gov

Challenges of building a new vaccine delivery platform for LMICs

Challenges of building a new vaccine delivery platform for LMICs Terri B. Hyde, MD MPH Immunizations Systems Branch, GID, CDC 23 March 2017 Immunization in the Elderly Geneva, Switzerland What has been

Midterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016

Midterm Review of the Global Measles and Rubella Strategic Plan 2012 2020 W. A. Orenstein, MD SAGE Geneva, 19 October 2016 1 Outline Strategic Plan 2012-2020 Progress toward milestones and goals Objectives

Immunization coverage and exemptions among Ontario s school pupils for : Findings and implications for future information systems

Immunization coverage and exemptions among Ontario s school pupils for 2011 12: Findings and implications for future information systems GH Lim, MA McIntyre, S Wilson PHO Ground Rounds August 20, 2013

APPENDIX EE VACCINE STATUS AND DATE

VACCINE STATUS AND DATE Vaccine Status, Date is a ten-character field which presents information about each of the vaccines required for children. For most cases, the first character tells the vaccine

Protocol Synopsis. Administrative information

Protocol Synopsis Item (SPIRIT item no.) Administrative information Title (1) Introduction Description of research question (6a) Description An optimal schedule for the post-polio eradication era: multicentre

Utah s Immunization Rule Individual Vaccine Requirements

Utah s Immunization Rule Individual Vaccine Requirements Which vaccines are required for school entry in Utah? Grades K-6: 5 doses DTaP (4 doses if the 4 th dose was given after the 4 th birthday) 4 doses

Vaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO

Vaccine Preventable Disease Surveillance: Overview Thomas Cherian, WHO Global Framework on Immunization Monitoring and Surveillance (GFIMS) l An extension of the GIVS, published on December 07 - http://www.who.int/immunization/en/

MODEL INSERT MEASLES, MUMPS AND RUBELLA (MMR) COMBINED VACCINE

MODEL INSERT MEASLES, MUMPS AND RUBELLA (MMR) COMBINED VACCINE DESCRIPTION The vaccine is a freeze-dried powder containing three viruses - measles, mumps and rubella. a) The measles vaccine component is

Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation

Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation Background Information Immunisation services in Syria Syria had good immunisation services,

Annotated Bibliography:

Annotated Bibliography: Montana Code Annotated 2009. Montana Legislative Services. September 10, 2010 http://data.opi.mt.gov/bills/mca/20/5/20-5-403.htm. A school may not allow a student to attend unless

Vaccines: The Real Story

Vaccines: The Real Story by, Ph.D. Qualifications Ph.D. in Nuclear Chemistry from the University of Rochester University Professor From 199-1995 NSF-Sponsored Scientist with More Than $2, In Research Grants

Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project,

Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project, 2009-2010 Linda Beer PhD, Christine L Mattson PhD, William Rodney Short MD,

Lessons from the Development of a Canadian National System of Surveillance

Lessons from the Development of a Canadian National System of Surveillance NATHALIE JETTÉ MD, MSc, FRCPC Assistant Professor Neurology Hotchkiss Brain Institute Calgary Institute of Population and Public

Global Epidemiology and Prevention of Hepatitis B

Global Epidemiology and Prevention of Hepatitis B Dr. Steven Wiersma WHO Geneva Strengthening immunisation systems and introduction of hepatitis B vaccine in Central and Eastern Europe and the Newly Independent

Decision-making by the Advisory Committee on Immunization Practices

Decision-making by the Advisory Committee on Immunization Practices Melinda Wharton, MD, MPH Deputy Director, National Center for Immunization & Respiratory Diseases Institute of Medicine 9 February 2012

School Year IN State Department of Health School Immunization Requirements Updated March to 5 years old

2013 2014 School Year IN State Department of Health School Immunization Requirements Updated March 2013 3 to 5 years old Kindergarten Grades 1 to 5 Grades 6 to 10 Grades 11 to 12 (Hepatitis B) 4 DTaP (Diphtheria,

MARYLAND STATE DEPARTMENT OF EDUCATION OFFICE OF CHILD CARE MEDICATION ADMINISTRATION AUTHORIZATION FORM

Child Care Program: MARYLAND STATE DEPARTMENT OF EDUCATION OFFICE OF CHILD CARE MEDICATION ADMINISTRATION AUTHORIZATION FORM This form must be completed fully in order for child care providers and staff

Adverse Events Following Immunisation

Adverse Events Following Immunisation (common, uncommon, shockin rare, and how do we know their likely cause?) Kevin Connolly Portiuncula Hospital, Sept. 18, 2017 Definitions Adverse Event (AE).. untoward

Update on Vaccine Recommendations. Objectives. Childhood Immunization Schedule At the Turn of the Century. New Horizons in Pediatrics April 30, 2017

Centers for for Disease Disease Control Control and and Prevention Prevention National Center for Immunization and Respiratory Diseases Update on Vaccine Recommendations New Horizons in Pediatrics April

School Nurse Regional Update School Year Immunizations COLORADO IMMUNIZATION BRANCH

School Nurse Regional Update 2017-18 School Year Immunizations COLORADO IMMUNIZATION BRANCH Talking Points Child Care Immunizations K through 12 th Grade Immunizations Official Medical and Non-Medical

Investigation of Reports to VAERS of Death after Vaccination

Investigation of Reports to VAERS of Death after Vaccination Robert Ball, MD, MPH, ScM Chief, Vaccine Safety Branch Office of Biostatistics and Epidemiology for IOM Immunization Safety Review Committee

Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures

ARTICLES Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures AUTHORS: Nicola P. Klein, MD, PhD, a Bruce Fireman, MS, a W. Katherine Yih, MPH, PhD, b Edwin Lewis, MPH, a

School Year ALASKA CHILD CARE & SCHOOL IMMUNIZATION REQUIREMENT CHANGES

2009 2010 School Year ALASKA CHILD CARE & SCHOOL IMMUNIZATION REQUIREMENT CHANGES EFFECTIVE JULY 1, 2009 ALASKA IMMUNIZATION PROGRAM (907) 269-8000 OR 1-888-430-4321 Varicella: Immunization Documentation

FLORIDA DEPARTMENT OF EDUCATION DOE INFORMATION DATA BASE REQUIREMENTS VOLUME I: AUTOMATED STUDENT INFORMATION SYSTEM AUTOMATED STUDENT DATA ELEMENTS

Vaccine Status, Date Definition/Domain Vaccine Status, Date is a ten-character field which presents information about each of the vaccines required for children. For most cases, the first character tells

School Immunization Requirements IN State Department of Health School Year FAQ s

Requirements & Compliance School Immunization Requirements IN State Department of Health 2014-2015 School Year FAQ s 1. Are there any new required immunizations for the 2014-2015 school year? Yes. Two

VACCINE-PREVENTABLE DISEASES (VPDS): CURRENT TRENDS

VACCINE-PREVENTABLE DISEASES (VPDS): CURRENT TRENDS Adult Immunization Conference April 10, 2018 Steve Fleming, EdM stephen.fleming@state.ma.us Presenter Disclosure Information I, Steve Fleming, have been

CHRONIC HEPATITIS B AND C COHORT STUDY (CHECS)

CHRONIC HEPATITIS B AND C COHORT STUDY (CHECS) CDC CONTACT Scott D Holmberg, M.D., M.P.H. Chief, Epidemiology and Surveillance Branch Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis,

BENEFITS OF FUNDING CHRONIC HEPATITIS B NYC S EXPERIENCE AND C SURVEILLANCE:

BENEFITS OF FUNDING CHRONIC HEPATITIS B AND C SURVEILLANCE: NYC S EXPERIENCE Katherine Bornschlegel, MPH New York City Department of Health and Mental Hygiene OUTLINE Background on chronic hep B and C

ST. JOSEPH'S SEMINARY 201 Seminary Avenue Yonkers, New York 10704

ST. JOSEPH'S SEMINARY 201 Seminary Avenue Yonkers, New York 10704 Auditor Application APPLICATION PROCEDURE All Auditors will be required to have a minimum of a Bachelor s Degree Those applying must submit

Immunization Policy & Forms. 33 Prospect Hill Road Cromwell, Connecticut / Tel. (860) Fax: (860) /

Offices of the Registrar and Rector Immunization Policy & Forms 33 Prospect Hill Road Cromwell, Connecticut 06416 / Tel. (860) 632-3010 Fax: (860) 632-3030 / registrar@holyapostles.edu POLICY 1 Connecticut

Molina Healthcare of CA Medi-Cal Wellness Services Bonus. MHC Quality Dept. Revised 12/15/17

Molina Healthcare of CA Medi-Cal Wellness Services Bonus MHC Quality Dept. Revised 12/15/17 Changes to the Wellness Service Bonus As of January 1, 2018 DHCS is sun-setting the Information Only PM160 form

FAQs about Changes to DHR Immunization Rules and Regulations

FAQs about Changes to DHR Immunization Rules and Regulations 1. What are the new immunization rules changes? The new immunization rules changes include 1 new definition and changes in 4 vaccine requirements.

Recommended Childhood Immunization Schedu...ates, January - December 2000, NP Central

Recommended Childhood Immunization Schedule United States, January - December 2000 Vaccines 1 are listed under routinely recommended ages. Solid-colored bars indicate range of recommended ages for immunization.

THIS FORM IS FOR MEDICAL STUDENTS ONLY IMMUNIZATION RECORD

Student Health Requirements Student health forms (physical exam and immunization records) are due in the Office of Clinical Education by March 1st for those students admitted on or before December 31st,

Risk of Intussusception after Monovalent Rotavirus Vaccination

original article Risk of Intussusception after Monovalent Rotavirus Vaccination Eric S. Weintraub, M.P.H., James Baggs, Ph.D., Jonathan Duffy, M.D., M.P.H., Claudia Vellozzi, M.D., M.P.H., Edward A. Belongia,

RUBELLA (GERMAN MEASLES) Includes Confirmed and Possible Cases

1 ID 11 RUBELLA (GERMAN MEASLES) Includes Confirmed and Possible Cases Background This case definition was developed by the Armed Forces Health Surveillance Branch (AFHSB) for the purpose of epidemiological

Immunize children and adults against vaccine-preventable disease in

PHD/CHSB & SH CHSB: Yvette Wright x1274, Teresa Moberly x1242 SHB: Helen Nace x1655, Jennifer Toma x8156 Program Purpose Program Information Immunize children and adults against vaccine-preventable disease

California 2010 Pertussis Epidemic. Kathleen Winter, MPH Immunization Branch California Department of Public Health

California 2010 Pertussis Epidemic Kathleen Winter, MPH Immunization Branch California Department of Public Health Overview Pertussis Background California Pertussis Epidemic Challenges and Success Ongoing

Recommended vaccines in the United States. Maki Kano, MD September 23, 2017 Apple Time

Recommended vaccines in the United States Maki Kano, MD September 23, 2017 Apple Time Recommended Vaccines 0 to 6 years old Recommended Vaccines 7 to 18 Vaccine schedule in Japan Vaccines in Japan Routine

The Vaccine Safety Datalink (VSD) Data Sharing Program

The Vaccine Safety Datalink (VSD) Data Sharing Program Melinda Wharton, MD, MPH Acting Deputy Director National Immunization Program Centers for Disease Control and Prevention VSD Data Sharing Program:

The Danish childhood vaccination program SUMMARY IN ENGLISH

The Danish childhood vaccination program SUMMARY IN ENGLISH 2018 Why do we vaccinate children in Denmark? Childhood immunization programs are some of the most effective preventive public health measures

Reanalysis of CDC Data on Autism Incidence and Time of First MMR Vaccination Brian S. Hooker, Ph.D., P.E.

Reanalysis of CDC Data on Autism Incidence and Time of First MMR Vaccination Brian S. Hooker, Ph.D., P.E. This study is a re-analysis of Centers for Disease Control and Prevention (CDC) data pertaining